Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
Oct 28, 16:00
Karolinska Development Profit Margin (Quarterly): -3.28K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.28K% |
| March 31, 2024 | 44.16% |
| December 31, 2023 | -351.0% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -5.11K% |
| December 31, 2022 | |
| September 30, 2022 | -8.85K% |
| June 30, 2022 | -3.59K% |
| March 31, 2022 | -4.95K% |
| December 31, 2021 | -4.16K% |
| September 30, 2021 | -240.4% |
| June 30, 2021 | |
| March 31, 2021 | -3.96K% |
| December 31, 2020 | |
| September 30, 2020 | -39.39K% |
| June 30, 2020 | |
| March 31, 2020 | -11.43K% |
| December 31, 2019 | |
| September 30, 2019 | -2.06K% |
| June 30, 2019 | |
| March 31, 2019 | -2.06K% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | -2.69K% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | -3.79K% |
| March 31, 2017 | -4.09K% |
| December 31, 2016 | -620.3% |
| September 30, 2016 | -4.11K% |
| June 30, 2016 | -12.49K% |
| March 31, 2016 | -16.46K% |
| December 31, 2015 | -23.94K% |
| September 30, 2015 | -8.49K% |
| June 30, 2015 | -58.55K% |
| March 31, 2015 | -25.29K% |
| December 31, 2014 | -2.96K% |
| September 30, 2014 | -10.90K% |
| June 30, 2014 | -17.26K% |
| March 31, 2014 | -1.47K% |
| December 31, 2013 | -10.50K% |
| September 30, 2013 | -5.85K% |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -6.58K% |
| June 30, 2012 | -2.89K% |
| March 31, 2012 | -3.31K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-39.39K%
Minimum
Sep 2020
44.16%
Maximum
Mar 2024
-7.10K%
Average
-4.06K%
Median
Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Calliditas Therapeutics AB | -8.48% |
| Oncopeptides AB | -1.45K% |
| BioInvent International AB | -761.8% |
| Hansa Biopharma AB | -213.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -0.46% |
| Return on Assets | -0.46% |
| Return on Invested Capital | -0.46% |
| Operating Margin (Quarterly) | -1.73K% |
| Return on Net Operating Assets | -120.0% |